Holen Sie sich die Stockscreener-App
3.25
0.00%
0.00
Schlusskurs vom Vortag:
$3.25
Offen:
$3.14
24-Stunden-Volumen:
153.95K
Relative Volume:
0.68
Marktkapitalisierung:
$33.63M
Einnahmen:
$114.70K
Nettoeinkommen (Verlust:
$-37.06M
KGV:
-0.8139
EPS:
-3.9929
Netto-Cashflow:
$-30.69M
1W Leistung:
+7.62%
1M Leistung:
+57.77%
6M Leistung:
+103.12%
1J Leistung:
-19.55%
1-Tages-Spanne:
$3.14
$3.33
1-Wochen-Bereich:
$2.9101
$3.33
52-Wochen-Spanne:
$1.00
$6.60
Sab Biotherapeutics Inc Stock (SABS) Company Profile
Firmenname
Sab Biotherapeutics Inc
Sektor
Branche
Telefon
305-845-2813
Adresse
777 W 41ST ST, MIAMI BEACH
Vergleichen Sie SABS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SABS
Sab Biotherapeutics Inc
|
3.23 | 33.84M | 114.70K | -37.06M | -30.69M | -3.9929 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.93 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.29 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
425.56 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
838.57 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Sab Biotherapeutics Inc Stock (SABS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-17 | Eingeleitet | Leerink Partners | Outperform |
| 2025-05-14 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-10-09 | Eingeleitet | Craig Hallum | Buy |
| 2024-08-28 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-05 | Eingeleitet | Chardan Capital Markets | Buy |
Sab Biotherapeutics Inc Aktie (SABS) Neueste Nachrichten
SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142 - Investing News Network
SAb Biotherapeutics (NASDAQ: SABS) shares SAB-142 Phase 1 safety, mechanism data at ISPAD - Stock Titan
SAB BIO to Participate in Upcoming Investor Conferences - The Manila Times
Will SAB Biotherapeutics Inc. stock deliver consistent dividendsJuly 2025 Short Interest & Weekly Breakout Opportunity Watchlist - newser.com
Why SAB Biotherapeutics Inc. Equity Warrant stock is considered a top pickWeekly Trade Summary & Daily Chart Pattern Signals - newser.com
Custom strategy builders for tracking SAB Biotherapeutics Inc. Equity Warrant - newser.com
Can trapped investors hope for a rebound in SAB Biotherapeutics Inc. Equity WarrantStock Surge & Safe Swing Trade Setups - newser.com
Why SAB Biotherapeutics Inc. stock remains a top recommendation2025 Trading Volume Trends & Safe Entry Zone Tips - newser.com
What sentiment indicators say about SAB Biotherapeutics Inc. stockPortfolio Return Report & Verified Chart Pattern Trade Signals - newser.com
How SAB Biotherapeutics Inc. stock reacts to job market data2025 Trading Recap & Daily Profit Maximizing Tips - newser.com
Is SAB Biotherapeutics Inc. stock safe for conservative investors - newser.com
Will SAB Biotherapeutics Inc. rebound enough to break evenWeekly Trade Review & Smart Investment Allocation Tips - newser.com
Using flow based indicators on SAB Biotherapeutics Inc. Equity WarrantJuly 2025 Snapshot & AI Enhanced Market Trend Forecasts - newser.com
Will SAB Biotherapeutics Inc. stock deliver better than expected guidanceEarnings Recap Report & Accurate Technical Buy Alerts - newser.com
Reversal indicators forming on SAB Biotherapeutics Inc. stock2025 Retail Activity & Reliable Trade Execution Plans - newser.com
Published on: 2025-11-03 08:31:25 - newser.com
What insider trading reveals about SAB Biotherapeutics Inc. Equity Warrant stockEarnings Recap Report & AI Driven Stock Price Forecasts - newser.com
Leading vs lagging indicators on SAB Biotherapeutics Inc. Equity Warrant performanceWeekly Risk Summary & AI Optimized Trading Strategy Guides - newser.com
Using Bollinger Bands to evaluate SAB Biotherapeutics Inc. Equity Warrant2025 Support & Resistance & Capital Protection Trading Alerts - newser.com
Why SAB Biotherapeutics Inc. Equity Warrant stock remains undervaluedWeekly Stock Report & Community Consensus Stock Picks - newser.com
Is SAB Biotherapeutics Inc. Equity Warrant reversing from oversold territoryPortfolio Value Report & Real-Time Market Trend Scan - newser.com
Why retail investors pile into SAB Biotherapeutics Inc. stockJuly 2025 Final Week & Capital Protection Trading Alerts - newser.com
Published on: 2025-11-03 03:47:26 - newser.com
Can SAB Biotherapeutics Inc. Equity Warrant stock hit record highs againPortfolio Return Summary & Safe Capital Growth Stock Tips - newser.com
Quantitative breakdown of SAB Biotherapeutics Inc. Equity Warrant recent moveTrade Volume Summary & Growth Focused Stock Reports - newser.com
Real time pattern detection on SAB Biotherapeutics Inc. Equity Warrant stock2025 EndofYear Setup & Growth Focused Stock Pick Reports - newser.com
Why SAB Biotherapeutics Inc. Equity Warrant stock remains on buy listsQuarterly Growth Report & Accurate Trade Setup Notifications - newser.com
Tick level data insight on SAB Biotherapeutics Inc. volatilityJuly 2025 Selloffs & Detailed Earnings Play Strategies - newser.com
Published on: 2025-11-02 20:28:45 - newser.com
Custom strategy builders for tracking SAB Biotherapeutics Inc.Trade Performance Summary & Verified Swing Trading Watchlists - newser.com
What analysts say about SAB Biotherapeutics Inc stockFlag and Pennant Patterns & Free Daily Stock Hotspot Analysis - earlytimes.in
Using data filters to optimize entry into SAB Biotherapeutics Inc. Equity WarrantLong Setup & Real-Time Buy Signal Notifications - newser.com
Will SAB Biotherapeutics Inc. Equity Warrant stock keep outperforming rivalsCPI Data & Stock Portfolio Risk Management - newser.com
Is SAB Biotherapeutics Inc. Equity Warrant a candidate for recovery play2025 Momentum Check & Real-Time Chart Pattern Alerts - newser.com
What hedge fund activity signals for SAB Biotherapeutics Inc. stockShare Buyback & Free Daily Entry Point Trade Alerts - newser.com
How SAB Biotherapeutics Inc. Equity Warrant stock benefits from global expansionWeekly Investment Summary & AI Optimized Trading Strategy Guides - newser.com
Can SAB Biotherapeutics Inc. Equity Warrant stock resist sector downturns2025 Trading Volume Trends & Long-Term Growth Stock Strategies - newser.com
Will SAB Biotherapeutics Inc. stock maintain dividend yield2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com
Ranking SAB Biotherapeutics Inc. Equity Warrant among high performing stocks via toolsMarket Activity Summary & Daily Technical Stock Forecast Reports - newser.com
Trend analysis for SAB Biotherapeutics Inc. Equity Warrant this weekWeekly Investment Summary & AI Optimized Trading Strategy Guides - newser.com
Is SAB Biotherapeutics Inc. forming a reversal patternStop Loss & Accurate Trade Setup Notifications - newser.com
Finanzdaten der Sab Biotherapeutics Inc-Aktie (SABS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sab Biotherapeutics Inc-Aktie (SABS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Sessa Capital (Master), L.P. | Director |
Sep 29 '25 |
Option Exercise |
1.75 |
1,740,000 |
3,045,000 |
2,198,457 |
1.31%
0.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):